In the biggest venture capital financing this week, clinical-stage radiopharmaceutical AdvanCell has closed a $315 million ...
In a promising development for cancer treatment, a collaborative research team has overcome two issues that have prevented ...
SCN2A‑related developmental epileptic encephalopathy (DEE) is a rare, severe form of childhood epilepsy and one of the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results